RxDoctor Payments Data

Edward Parry, NP

Family · Vineyard, UTNPI 1104370436

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.3% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $3,828, 8.0 times the $476 reported in 2021. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,582in general payments, 2019–2025

Across 221 payments — averaging $43.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Medtronic$1K
  • Nevro Corp.$890
  • Relievant Medsystems, Inc.$347
  • Globus Medical$187
  • Averitas Pharma Inc.$113
  • plus $234 from 6 others

What the payments were for

  • Speaking & faculty fees$4,44046%
  • Travel & lodging$1,23613%
  • Food & beverage$3,86040%
  • Education$450%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,582 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Medicare billing

Part B allowed, 2024
$117,213
Medicare patients
265
Services billed
4,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine74$20,460
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen497$18,625
NucyntaTapentadol Hcl13$16,792
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen384$12,430
Oxycodone Hcl238$5,459
Gabapentin200$4,698
Fentanyl46$4,482
Pregabalin277$4,198
Celecoxib132$3,629
Tizanidine Hcl260$3,524
Buprenorphine Hcl118$3,076
Tramadol Hcl245$2,685
Diclofenac Sodium89$1,656
Morphine Sulfate ErMorphine Sulfate73$1,469
Baclofen73$1,300

Paid to pharmacies, not to this prescriber.

Other family in Vineyard

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →